About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Management

 
 

11/17/2014 - Daxor Corporation Announces Payment of a Dividend

  

11/3/2014 - Daxor Announces Publication of a Study Comparing Two Widely Used Surrogate Tests for Estimating Blood Volume with Direct Measurement of Blood Volume

  

10/21/2014 - Daxor Corporation Announces Research Agreement with Virginia Commonwealth University on Burn Patients

  
 

______________________

 
     
  Form N-Q for Sep 30, 2014  
  Form N-CSR for Jun 30, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Mar 31, 2014  
 

 

 
Executive Team

Joseph Feldschuh, M.D.

President and CEO

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Gary Fischman, Ph.D.

Vice President, Research and Development
   
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

Michael R. Feldschuh

Director of the Company

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company
   
Medical Advisory Board  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2014 DAXOR Corporation. All Rights Reserved.